The strategy of blocking the assembly of active CRTC-CREB transcriptional complex and subsequently inhibiting extensive CRTC target genes has the advantage of simultaneously inhibiting multiple deleterious cell signals which predicts a greater challenge for resistant cancer cell clones to emerge. The gene discussed is CREB1; the disease is cancer.